You are here

Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds

Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds | 02 July 2020 | A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday. Officials with the Michigan health system said the study found the drug "significantly" decreased the death rate of patients involved in the analysis. The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.